Aminophenols
Aobchem 1-Bromo-3 4-difluoro-2 5-dimethylbenzene | 95% | CAS 2969357-28-4 | C8H7BrF2 | 500mg
1-Bromo-3 4-difluoro-2 5-dimethylbenzene | 95% | CAS 2969357-28-4 | C8H7BrF2 | 500mg
Aobchem 1-Bromo-3 4-difluoro-2 5-dimethylbenzene | 95% | CAS 2969357-28-4 | C8H7BrF2 | 5g
1-Bromo-3 4-difluoro-2 5-dimethylbenzene | 95% | CAS 2969357-28-4 | C8H7BrF2 | 5g
Aobchem 1-Bromo-3 5-difluoro-2 4-dimethoxybenzene | 95% | CAS 2969447-54-7 | C8H7BrF2O2 | 250mg
1-Bromo-3 5-difluoro-2 4-dimethoxybenzene | 95% | CAS 2969447-54-7 | C8H7BrF2O2 | 250mg
Aobchem 3-Bromo-1 4-difluoro-2 5-dimethoxybenzene | 95% | C8H7BrF2O2 | 1g
3-Bromo-1 4-difluoro-2 5-dimethoxybenzene | 95% | C8H7BrF2O2 | 1g
=O | 5g | 205388951](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00128114-205388951.PNG-250.jpg)
eMolecules 2-Amino-4-chloro-5-nitrophenol | Combi-BlocksMFCD00010300 | 188.570 | C6H5ClN2O3 | 98.000 | Nc1cc(Cl)c(cc1O)[N+]([O-])=O | 5g | 205388951
2-Amino-4-chloro-5-nitrophenol | Combi-BlocksMFCD00010300 | 188.570 | C6H5ClN2O3 | 98.000 | Nc1cc(Cl)c(cc1O)[N+]([O-])=O | 5g | 205388951
Medchemexpress LLC RS100329 hydrochloride | 1215654-26-4 | 99.6% | 462.89 g/mol | C20H26ClF3N4O3 | 5 MG
RS100329 hydrochloride is a selective α1A-adrenoceptor antagonist for research use that inhibits reflex urethral contractions and is used in studies of benign prostatic hyperplasia. The compound is supplied as the hydrochloride salt with high analytical purity and characterized molecular properties.
- CAS number 1215654-26-4.
- Molecular formula C20H26ClF3N4O3.
- Molecular weight 462.89 g/mol.
- Purity 99.6%.
- Solubility in DMSO 31.25 mg/mL (67.51 mM); ultrasonic assistance recommended.
- Recommended storage solid at 4°C, protect from light; in solvent -80°C for up to 6 months, -20°C for up to 1 month.
- Intended for research use only; not for human or veterinary use.
Medchemexpress LLC WR99210 hydrochlorid 5mg | 30711-93-4 | 5 MG
WR99210 hydrochloride is a potent dihydrofolate reductase (DHFR) inhibitor used in research on Plasmodium spp. and Toxoplasma gondii, and commonly used for selection of Plasmodium transfectants. The compound is supplied as the hydrochloride salt and is intended for laboratory research use only.
- Potent DHFR inhibitor (IC50 <0.075 nM).
- Used for antimalarial research and parasite selection.
- Supplied as a hydrochloride salt for improved solubility.
- Suitable for storage at -20°C in sealed containers away from moisture.
- Available in small research quantities for lab use (e.g., 5 mg).
Medchemexpress LLC DiAzKs hydrochlorid 10mM 1mL | 2421187-79-1 | 98.0% | 10MM/1ML
DiAzKs (H-L-Photo-lysine) hydrochloride is a diazirine-containing lysine amino acid and a photo-cross-linker. It can be site-selectively incorporated into proteins and is used to crosslink protein-protein interactions in vitro and in living cells. This compound acts as a UV light-activated photo-crosslinking probe.
- Site-selective incorporation into proteins.
- Crosslinks protein-protein interactions.
- UV light-activated photo-crosslinking probe.
- Used in vitro and in living cells.
Chemscene ChemScene | (S)-Ethyl 2-ethoxy-3-(4-hydroxyphenyl)propanoate | 250MG | CS-0151952 | 0.98 | 222555-06-8| MFCD06796580 | 238.28
ChemScene | (S)-Ethyl 2-ethoxy-3-(4-hydroxyphenyl)propanoate | 250MG | CS-0151952 | 0.98 | 222555-06-8| MFCD06796580 | 238.28
TARGETMOL CHEMICALS INC ECOPLADIB 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Ecopladib (PLA 725) is a sub-micromolar inhibitor of cytosolic phospholipase A2(alpha) (cPLA2(alpha)) with IC50s of 0.15 uM and 0.11 uM in the GLU micelle and rat whole blood assays respectively. purity: 99%
Medchemexpress LLC SR9011 hydrochloride | 2070014-94-5 | 99.0% | 515.50 | 1 ML
SR9011 hydrochloride is a REV-ERBα/β agonist with IC50s of 790 nM and 560 nM for REV-ERBα and REV-ERBβ, respectively. This compound offers several key features and benefits:
- Acts as a REV-ERBα/β agonist
- Suppresses the expression of BMAL1 mRNA in HepG2 cells in a REV-ERBα/β-dependent manner
- Suppresses proliferation of breast cancer cell lines
- Appears to pause the cell cycle of breast cancer cells prior to M phase
- Causes an increase in cells in the G0/G1 phase and a decrease of cells in S and G2/M phase
- Displays reasonable plasma exposure in vivo
- Suppresses plasminogen activator inhibitor type 1 gene (Serpine1), cholesterol 7α-hydroxylase (Cyp7a1), and sterol response element binding protein (Srepf1) in a dose-dependent manner in mice
- Administration to mice results in loss of locomotor activity during the subject dark phase